Reduced anxiety-like and depression-related behavior in neuropeptide Y Y4 receptor knockout mice

Genes, Brain and Behavior

Volumn 7, Issue 5, 2008, Pages 532-542

  Painsipp, E ^a   Wultsch, T ^a,b   Edelsbrunner, M E ^a   Tasan, R O ^c   Singewald, N ^c   Herzog, H ^d   Holzer, P ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

^b UNIVERSITY OF WÜRZBURG   (Germany)

^c INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^d GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

Anxiety related behavior; Depression related behavior; Elevated plus maze test; Home cage activity; Neuropeptide Y; Object recognition; Open field test; Tail suspension test; Y2 receptors; Y4 receptors

Indexed keywords

NEUROPEPTIDE Y4 RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY DISORDER; ARTICLE; CONTROLLED STUDY; DEPRESSION; EMOTIONALITY; FEMALE; GENOTYPE; HOMEOSTASIS; HYPERTHERMIA; IMMOBILIZATION; LEARNING; MAZE TEST; MEMORY; NONHUMAN; OPEN FIELD BEHAVIOR; PRIORITY JOURNAL; RECOGNITION; RECTUM TEMPERATURE;

ANIMALS; ANXIETY; BEHAVIOR, ANIMAL; CORTICOSTERONE; DEPRESSION; EXPLORATORY BEHAVIOR; FEMALE; FEVER; MAZE LEARNING; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RECEPTORS, NEUROPEPTIDE Y; RECOGNITION (PSYCHOLOGY); STRESS, PHYSIOLOGICAL;

ANIMALIA; MUS; RODENTIA;

EID: 47249084672     PISSN: 16011848     EISSN: 1601183X     Source Type: Journal    
DOI: 10.1111/j.1601-183X.2008.00389.x     Document Type: Article

References (63)

1. Acuna-Goycolea, C., Tamamaki, N., Yanagawa, Y., Obata, K. van den Pol, A.N 2005) Mechanisms of neuropeptide Y, peptide YY, and pancreatic polypeptide inhibition of identified green fluorescent protein-expressing GABA neurons in the hypothalamic neuroendocrine arcuate nucleus. J Neurosci 25, 7406 7419.
2. Asakawa, A., Inui, A., Ueno, N., Fujimiya, M., Fujino, M.A. Kasuga, M 1999) Mouse pancreatic polypeptide modulates food intake, while not influencing anxiety in mice. Peptides 20, 1445 1448.
3. Asakawa, A., Inui, A., Yuzuriha, H., Ueno, N., Katsuura, G., Fujimiya, M., Fujino, M.A., Niijima, A., Meguid, M.M. Kasuga, M 2003) Characterization of the effects of pancreatic polypeptide in the regulation of energy balance. Gastroenterology 124, 1325 1336.
4. Bacchi, F., Mathe, A.A., Jimenez, P., Stasi, L., Arban, R., Gerrard, P. Caberlotto, L 2006) Anxiolytic-like effect of the selective neuropeptide Y Y2 receptor antagonist BIIE0246 in the elevated plus-maze. Peptides 27, 3202 3207.
5. Belzung, C. Griebel, G 2001) Measuring normal and pathological anxiety-like behaviour in mice: a review. Behav Brain Res 125, 141 149.
6. Campbell, R.E., Smith, M.S., Allen, S.E., Grayson, B.E., Ffrench-Mullen, J.M. Grove, K.L 2003) Orexin neurons express a functional pancreatic polypeptide Y4 receptor. J Neurosci 23, 1487 1497.
7. Cryan, J.F. Mombereau, C 2004) In search of a depressed mouse: utility of models for studying depression-related behavior in genetically modified mice. Mol Psychiatry 9, 326 357.
8. Cryan, J.F., Mombereau, C. Vassout, A 2005) The tail suspension test as a model for assessing antidepressant activity: review of pharmacological and genetic studies in mice. Neurosci Biobehav Rev 29, 571 625.
9. DiMicco, J.A., Sarkar, S., Zaretskaia, M.V. Zaretsky, D.V 2006) Stress-induced cardiac stimulation and fever: common hypothalamic origins and brainstem mechanisms. Auton Neurosci 126-127, 106 119.
10. Dodart, J.C., Mathis, C. Ungerer, A 1997) Scopolamine-induced deficits in a two-trial object recognition task in mice. NeuroReport 8, 1173 1178.
11. Dumont, Y., Jacques, D., Bouchard, P. Quirion, R 1998) Species differences in the expression and distribution of the neuropeptide Y Y1, Y2, Y4, and Y5 receptors in rodents, guinea pig, and primates brains. J Comp Neurol 402, 372 384.
12. Dumont, Y., Moyse, E., Fournier, A. Quirion, R 2007) Distribution of peripherally injected peptide YY ([125I] PYY (3-36)) and pancreatic polypeptide ([125I] hPP) in the CNS: enrichment in the area postrema. J Mol Neurosci 33, 294 304.
13. Ennaceur, A. Delacour, J 1988) A new one-trial test for neurobiological studies of memory in rats. 1: behavioral data. Behav Brain Res 31, 47 59.
14. Fetissov, S.O., Kopp, J. Hökfelt, T 2004) Distribution of NPY receptors in the hypothalamus. Neuropeptides 38, 175 188.
15. File, S.E. (2001) Factors controlling measures of anxiety and responses to novelty in the mouse. Behav Brain Res 125, 151 157.
16. Flood, J.F., Baker, M.L., Hernandez, E.N. Morley, J.E 1989) Modulation of memory processing by neuropeptide Y varies with brain injection site. Brain Res 503, 73 82.
17. Gorman, J.M 2006) Gender differences in depression and response to psychotropic medication. Gend Med 3, 93 109.
18. Greco, B. Carli, M 2006) Reduced attention and increased impulsivity in mice lacking NPY Y2 receptors: relation to anxiolytic-like phenotype. Behav Brain Res 169, 325 334.
19. Harro, J 2006) CCK and NPY as anti-anxiety treatment targets: promises, pitfalls, and strategies. Amino Acids 31, 215 230.
20. Heilig, M 2004) The NPY system in stress, anxiety and depression. Neuropeptides 38, 213 224.
21. Holsboer, F. (2000) The corticosteroid receptor hypothesis of depression. Neuropsychopharmacology 23, 477 501.
22. Karl, T. Herzog, H 2007) Behavioral profiling of NPY in aggression and neuropsychiatric diseases. Peptides 28, 326 333.
23. Karl, T., Burne, T.H. Herzog, H 2006) Effect of Y1 receptor deficiency on motor activity, exploration, and anxiety. Behav Brain Res 167, 87 93.
24. Kask, A., Harro, J., von Horsten, S., Redrobe, J.P., Dumont, Y. Quirion, R 2002) The neurocircuitry and receptor subtypes mediating anxiolytic-like effects of neuropeptide Y. Neurosci Biobehav Rev 26, 259 283.
25. de Kloet, E.R. (2003) Hormones, brain and stress. Endocr Regul 37, 51 68.
26. Larsen, P.J. Kristensen, P 1997) The neuropeptide Y (Y4) receptor is highly expressed in neurones of the rat dorsal vagal complex. Mol Brain Res 48, 1 6.
27. Lin, S., Boey, D. Herzog, H 2004) NPY and Y receptors: lessons from transgenic and knockout models. Neuropeptides 38, 189 200.
28. Liu, X. Gershenfeld, H.K 2001) Genetic differences in the tail-suspension test and its relationship to imipramine response among 11 inbred strains of mice. Biol Psychiatry 49, 575 581.
29. Liu, X., Peprah, D. Gershenfeld, H.K 2003) Tail-suspension induced hyperthermia: a new measure of stress reactivity. J Psychiatr Res 37, 249 259.
30. Lundell, I., Statnick, M.A., Johnson, D., Schober, D.A., Starbäck, P., Gehlert, D.R. Larhammar, D 1996) The cloned rat pancreatic polypeptide receptor exhibits profound differences to the orthologous receptor. Proc Natl Acad Sci U S A 93, 5111 5115.
31. Michel, M.C., Beck-Sickinger, A., Cox, H., Doods, H.N., Herzog, H., Larhammar, D., Quirion, R., Schwartz, T. Westfall, T 1998) XVI. International Union of Pharmacology recommendations for the nomenclature of neuropeptide Y, peptide YY, and pancreatic polypeptide receptors. Pharmacol Rev 50, 143 150.
32. Müller, M.B., Zimmermann, S., Sillaber, I., Hagemeyer, T.P., Deussing, J.M., Timpl, P., Kormann, M.S., Droste, S.K., Kuhn, R., Reul, J.M., Holsboer, F. Wurst, W 2003) Limbic corticotropin-releasing hormone receptor 1 mediates anxiety-related behavior and hormonal adaptation to stress. Nat Neurosci 6, 1100 1107.
33. Oka, T., Oka, K. Hori, T 2001) Mechanisms and mediators of psychological stress-induced rise in core temperature. Psychosom Med 63, 476 486.
34. Olivier, B., Zethof, T., Pattij, T., van Boogaert, M., van Oorschot, R., Leahy, C., Oosting, R., Bouwknecht, A., Veening, J., van der Gugten, J. Groenink, L 2003) Stress-induced hyperthermia and anxiety: pharmacological validation. Eur J Pharmacol 463, 117 132.
35. Oshima, A., Flachskamm, C., Reul, J.M., Holsboer, F. Linthorst, A.C 2003) Altered serotonergic neurotransmission but normal hypothalamic-pituitary- adrenocortical axis activity in mice chronically treated with the corticotropin-releasing hormone receptor type 1 antagonist NBI 30775. Neuropsychopharmacology 28, 2148 2159.
36. Painsipp, E., Wultsch, T., Shahbazian, A., Edelsbrunner, M., Kreissl, M.C., Schirbel, A., Bock, E., Pabst, M.A., Thoeringer, C.K., Huber, H.P. Holzer, P 2007) Experimental gastritis in mice enhances anxiety in a gender-related manner. Neuroscience 150, 522 536.
37. Palanza, P. (2001) Animal models of anxiety and depression: how are females different? Neurosci Biobehav Rev 25, 219 233.
38. Parker, R.M. Herzog, H 1999) Regional distribution of Y-receptor subtype mRNAs in rat brain. Eur J Neurosci 11, 1431 1448.
39. Pellow, S. File, S.E 1986) Anxiolytic and anxiogenic drug effects on exploratory activity in an elevated plus-maze: a novel test of anxiety in the rat. Pharmacol Biochem Behav 24, 525 529.
40. Peloso, E., Wachulec, M. Satinoff, E 2002) Stress-induced hyperthermia depends on both time of day and light condition. J Biol Rhythms 17, 164 170.
41. Primeaux, S.D., Wilson, S.P., Cusick, M.C., York, D.A. Wilson, M.A 2005) Effects of altered amygdalar neuropeptide Y expression on anxiety-related behaviors. Neuropsychopharmacology 30, 1589 1597.
42. Redrobe, J.P., Dumont, Y., Fournier, A. Quirion, R 2002) The neuropeptide Y (NPY) Y1 receptor subtype mediates NPY-induced antidepressant-like activity in the mouse forced swimming test. Neuropsychopharmacology 26, 615 624.
43. Redrobe, J.P., Dumont, Y., Herzog, H. Quirion, R 2003) Neuropeptide Y (NPY) Y2 receptors mediate behaviour in two animal models of anxiety: evidence from Y2 receptor knockout mice. Behav Brain Res 141, 251 255.
44. Redrobe, J.P., Carvajal, C., Kask, A., Dumont, Y. Quirion, R 2004a) Neuropeptide Y and its receptor subtypes in the central nervous system: emphasis on their role in animal models of psychiatric disorders. In Michel, M.C ed Neuropeptide Y and Related Peptides. Handbook of Experimental Pharmacology Volume 162. Springer, Berlin, pp. 101 136.
45. Redrobe, J.P., Dumont, Y., Herzog, H. Quirion, R 2004b) Characterization of neuropeptide Y, Y2 receptor knockout mice in two animal models of learning and memory processing. J Mol Neurosci 22, 159 166.
46. Sainsbury, A., Schwarzer, C., Couzens, M., Fetissov, S., Fürtinger, S., Jenkins, A., Cox, H.M., Sperk, G., Hökfelt, T. Herzog, H 2002a) Important role of hypothalamic Y2 receptors in body weight regulation revealed in conditional knockout mice. Proc Natl Acad Sci U S A 99, 8938 8943.
47. Sainsbury, A., Schwarzer, C., Couzens, M. Herzog, H 2002b) Y2 receptor deletion attenuates the type 2 diabetic syndrome of ob/ob mice. Diabetes 51, 3420 3427.
48. Sainsbury, A., Schwarzer, C., Couzens, M., Jenkins, A., Oakes, S.R., Ormandy, C.J. Herzog, H. (2002c) Y4 receptor knockout rescues fertility in ob/ob mice. Genes Dev 16, 1077 1088.
49. Sajdyk, T.J., Schober, D.A., Smiley, D.L. Gehlert, D.R 2002) Neuropeptide Y-Y2 receptors mediate anxiety in the amygdala. Pharmacol Biochem Behav 71, 419 423.
50. Sajdyk, T.J., Shekhar, A. Gehlert, D.R 2004) Interactions between NPY and CRF in the amygdala to regulate emotionality. Neuropeptides 38, 225 234.
51. Sajdyk, T.J., Fitz, S.D. Shekhar, A 2006) The role of neuropeptide Y in the amygdala on corticotropin-releasing factor receptor-mediated behavioral stress responses in the rat. Stress 9, 21 28.
52. Shekhar, A., Truitt, W., Rainnie, D. Sajdyk, T 2005) Role of stress, corticotrophin releasing factor (CRF) and amygdala plasticity in chronic anxiety. Stress 8, 209 219.
53. Simonds, V.M. Whiffen, V.E 2003) Are gender differences in depression explained by gender differences in co-morbid anxiety? J Affect Disord 77, 197 202.
54. Stanic, D., Brumovsky, P., Fetissov, S., Shuster, S., Herzog, H. Hökfelt, T 2006) Characterization of neuropeptide Y2 receptor protein expression in the mouse brain. I. Distribution in cell bodies and nerve terminals. J Comp Neurol 499, 357 390.
55. Steru, L., Chermat, R., Thierry, B. Simon, P 1985) The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacology (Berl) 85, 367 370.
56. 2 receptors in the mouse brain. BMC Pharmacol 7 (Suppl. 2 A14.
57. Theander-Carrillo, C., Wiedmer, P., Cettour-Rose, P., Nogueiras, R., Perez-Tilve, D., Pfluger, P., Castaneda, T.R., Muzzin, P., Schürmann, A., Szanto, I., Tschöp, M.H. Rohner-Jeanrenaud, F 2006) Ghrelin action in the brain controls adipocyte metabolism. J Clin Invest 116, 1983 1993.
58. Thorsell, A., Michalkiewicz, M., Dumont, Y., Quirion, R., Caberlotto, L., Rimondini, R., Mathe, A.A. Heilig, M 2000) Behavioral insensitivity to restraint stress, absent fear suppression of behavior and impaired spatial learning in transgenic rats with hippocampal neuropeptide Y overexpression. Proc Natl Acad Sci U S A 97, 12852 12857.
59. Tschenett, A., Singewald, N., Carli, M., Balducci, C., Salchner, P., Vezzani, A., Herzog, H. Sperk, G 2003) Reduced anxiety and improved stress coping ability in mice lacking NPY-Y2 receptors. Eur J Neurosci 18, 143 148.
60. Ueno, N., Asakawa, A., Satoh, Y. Inui, A 2007) Increased circulating cholecystokinin contributes to anorexia and anxiety behavior in mice overexpressing pancreatic polypeptide. Regul Pept 141, 8 11.
61. Wultsch, T., Painsipp, E., Donner, S., Sperk, G., Herzog, H., Peskar, B.A. Holzer, P 2006) Selective increase of dark phase water intake in neuropeptide-Y Y2 and Y4 receptor knockout mice. Behav Brain Res 168, 255 260.
62. Yannielli, P.C. Harrington, M.E 2001) Neuropeptide Y in the mammalian circadian system: effects on light-induced circadian responses. Peptides 22, 547 556.
63. Zethof, T.J., Van der Heyden, J.A., Tolboom, J.T. Olivier, B 1994) Stress-induced hyperthermia in mice: a methodological study. Physiol Behav 55, 109 115.